Wave Life Sciences Share Price Today
(NASDAQ: WVE)

Name: Wave Life Sciences Share Price Today (NASDAQ: WVE) - Wave Life Sciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Wave Life Sciences share price is $10.57 & ₹919.26 as on 6 Mar 2025, 2.30 'hrs' IST

$10.57

▲

-0.66

(-5.88%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Wave Life Sciences share price in Dollar and Rupees. Guide to invest in Wave Life Sciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Wave Life Sciences, along with analyst recommendations, forecasts, and comprehensive financials.

Wave Life Sciences share price movements

Today's Low: $10.08
Today's High: $11.42
$10.57
4.64%
Downside
Day's Volatility :11.73%
Upside
7.44%
52 Weeks Low: $4.25
52 Weeks High: $16.74
$10.57
59.79%
Downside
52 Weeks Volatility :74.6%
Upside
36.84%

Wave Life Sciences (WVE) Returns

Period	Wave Life Sciences Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	-22.23%	2.1%	0.0%
6 Months	114.72%	-4.1%	0.0%
1 Year	78.54%	2.2%	0.0%
3 Years	437.32%	11.8%	-11.6%

Wave Life Sciences (WVE) Key Statistics

in dollars & INR

Previous Close	$11.23
Open	$11.13
Today's High	$11.42
Today's Low	$10.08
Market Capitalization	$1.5B
Today's Volume	$539.6K
52 Week High	$16.735
52 Week Low	$4.25
Revenue TTM	$53.6M
EBITDA	$-148.0M
Earnings Per Share (EPS)	$-1.12
Profit Margin	-265.84%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-243.82%

How to invest in Wave Life Sciences Stock (WVE) from India?

It is very easy for Indian residents to invest directly in Wave Life Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Wave Life Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Wave Life Sciences or WVE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Wave Life Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Wave Life Sciences shares which would translate to 0.082 fractional shares of Wave Life Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Wave Life Sciences, in just a few clicks!

Returns in Wave Life Sciences (WVE) for Indian investors in Rupees

The Wave Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Wave Life Sciences investment value today

Current value as on today

₹1,73,007

Returns

₹73,007

(+73.01%)

Returns from Wave Life Sciences Stock

₹68,045 (+68.04%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Wave Life Sciences (WVE)

17%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Wave Life Sciences Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Wave Life Sciences

RA Capital Management, LLC
11.93%
Adage Capital Partners Gp LLC
6.31%
BlackRock Inc
6.14%
Maverick Capital Ltd
5.42%
Driehaus Capital Management LLC
4.40%
M28 Capital Management LP
3.71%

Analyst Recommendation on Wave Life Sciences

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Wave Life Sciences(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Wave Life Sciences Stock (WVE)

What analysts predicted

Upside of 114.16%

Target:

$22.64

Current:

$10.57

Insights on Wave Life Sciences Stock (Ticker Symbol: WVE)

Price Movement
In the last 3 years, WVE stock has moved up by 384.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 19.69M → -7.67M (in $), with an average decrease of 139.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, 7.25M → -61.78M (in $), with an average decrease of 127.6% per quarter

WVE Wave Life Sciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$14.4M	↑ 289.15%
Net Income	$-146.7M	↑ 43.73%
Net Profit Margin	-1.0K%	↑ 1737.29%

	FY19	Y/Y Change
Revenue	$16.0M	↑ 10.89%
Net Income	$-179.5M	↑ 22.4%
Net Profit Margin	-1.1K%	↓ 105.61%

	FY20	Y/Y Change
Revenue	$20.1M	↑ 25.61%
Net Income	$-149.9M	↓ 16.48%
Net Profit Margin	-746.68%	↑ 376.36%

	FY21	Y/Y Change
Revenue	$41.0M	↑ 104.03%
Net Income	$-122.2M	↓ 18.45%
Net Profit Margin	-298.42%	↑ 448.26%

	FY22	Y/Y Change
Revenue	$3.6M	↓ 91.09%
Net Income	$-161.8M	↑ 32.38%
Net Profit Margin	-4.4K%	↓ 4136.3%

	FY23	Y/Y Change
Revenue	$113.3M	↑ 3005.1%
Net Income	$-57.5M	↓ 64.46%
Net Profit Margin	-50.76%	↑ 4383.96%

	Q2 FY23	Q/Q Change
Revenue	$22.1M	↑ 70.98%
Net Income	$-21.1M	↓ 13.95%
Net Profit Margin	-95.47%	↑ 94.22%

	Q3 FY23	Q/Q Change
Revenue	$49.2M	↑ 122.63%
Net Income	$7.3M	↓ 134.36%
Net Profit Margin	14.74%	↑ 110.21%

	Q4 FY23	Q/Q Change
Revenue	$29.1M	↓ 40.96%
Net Income	$-16.3M	↓ 324.16%
Net Profit Margin	-55.95%	↓ 70.69%

	Q1 FY24	Q/Q Change
Revenue	$12.5M	↓ 56.85%
Net Income	$-31.6M	↑ 94.13%
Net Profit Margin	-251.7%	↓ 195.75%

	Q2 FY24	Q/Q Change
Revenue	$19.7M	↑ 57.06%
Net Income	$-32.9M	↑ 4.33%
Net Profit Margin	-167.19%	↑ 84.51%

	Q3 FY24	Q/Q Change
Revenue	$-7.7M	↓ 138.98%
Net Income	$-61.8M	↑ 87.65%
Net Profit Margin	804.85%	↑ 972.04%

	FY18	Y/Y Change
Profit	$14.4M	↓ 119.06%

	FY19	Y/Y Change
Profit	$-159.4M	↓ 1206.2%

	FY20	Y/Y Change
Profit	$-104.1M	↓ 34.72%

	FY21	Y/Y Change
Profit	$-80.9M	↓ 22.27%

	FY22	Y/Y Change
Profit	$3.6M	↓ 104.51%

	FY23	Y/Y Change
Profit	$104.1M	↑ 2752.81%

	Q2 FY23	Q/Q Change
Profit	$19.8M	↑ 88.58%

	Q3 FY23	Q/Q Change
Profit	$47.0M	↑ 137.31%

	Q4 FY23	Q/Q Change
Profit	$26.9M	↓ 42.76%

	Q1 FY24	Q/Q Change
Profit	$10.4M	↓ 61.45%

	Q2 FY24	Q/Q Change
Profit	$-20.7M	↓ 299.8%

	Q3 FY24	Q/Q Change
Profit	$-7.7M	↓ 62.92%

	FY18	Y/Y Change
Operating Cash Flow	$-22.9M	↓ 72.68%
Investing Cash Flow	$-9.9M	↓ 47.38%
Financing Cash Flow	$65.1M	↓ 31.03%

	FY19	Y/Y Change
Operating Cash Flow	$-188.2M	↑ 723.34%
Investing Cash Flow	$-3.9M	↓ 60.58%
Financing Cash Flow	$164.4M	↑ 152.56%

	FY20	Y/Y Change
Operating Cash Flow	$-116.0M	↓ 38.38%
Investing Cash Flow	$-1.3M	↓ 65.85%
Financing Cash Flow	$154.5M	↓ 6.0%

	FY21	Y/Y Change
Operating Cash Flow	$-89.0M	↓ 23.27%
Investing Cash Flow	$-560.0K	↓ 58.15%
Financing Cash Flow	$55.8M	↓ 63.87%

	FY22	Y/Y Change
Operating Cash Flow	$-127.8M	↑ 43.59%
Investing Cash Flow	$-1.3M	↑ 124.11%
Financing Cash Flow	$67.2M	↑ 20.35%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-37.3M	↓ 143.56%
Investing Cash Flow	$-72.0K	↓ 85.28%
Financing Cash Flow	$1.8M	↓ 94.73%

Wave Life Sciences Technicals Summary

Sell

Neutral

Buy

Wave Life Sciences is currently in a neutral trading position according to technical analysis indicators.

Wave Life Sciences (WVE) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Wave Life Sciences Ltd	-5.31%	114.72%	78.54%	437.32%	29.68%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Wave Life Sciences Ltd	NA	NA	0.0	-1.16	-2.44	-0.34	NA	0.95
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Wave Life Sciences Ltd	Buy	$1.5B	29.68%	NA	-265.84%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Wave Life Sciences

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Organization	Wave Life Sciences
Employees	266
CEO	Dr. Paul B. Bolno M.B.A., M.D.
Industry	Health Technology

Management People of Wave Life Sciences

Name	Title
Dr. Paul B. Bolno M.B.A., M.D.	President, CEO & Director
Mr. Kyle B. Moran CFA	CFO & Principal Accounting Officer
Dr. Chandra Vargeese Ph.D.	Chief Technology Officer
Dr. Erik Ingelsson M.D., Ph.D.	Chief Scientific Officer
Ms. Kate Rausch	Head of Investor Relations
Ms. Linda Rockett J.D.	Senior VP & General Counsel
Dr. Christopher Francis Ph.D.	Senior VP of Corporate Development & Head of Emerging Areas
Ms. Daryn Lewis	Senior VP & Head of Human Resources
Dr. Sridhar Vaddeboina Ph.D.	Senior Vice President of Chemistry, Manufacturing & Controls
Dr. Hsiu-Chiung Yang Ph.D.	Senior Vice President of Translational Medicine

Important FAQs about investing in WVE Stock from India :

What is Wave Life Sciences share price today?

Wave Life Sciences share price today stands at $10.57, Open: $11.13 ; Previous Close: $11.23 ; High: $11.42 ; Low: $10.08 ; 52 Week High: $16.74 ; 52 Week Low: $4.25.

The stock opens at $11.13, after a previous close of $11.23. The stock reached a daily high of $11.42 and a low of $10.08, with a 52-week high of $16.74 and a 52-week low of $4.25.

Can Indians buy Wave Life Sciences shares?

Yes, Indians can invest in the Wave Life Sciences (WVE) from India.

With INDmoney, you can buy Wave Life Sciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Wave Life Sciences at zero transaction cost.

How can I buy Wave Life Sciences shares from India?

It is very easy to buy Wave Life Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Wave Life Sciences (WVE) be purchased?

Yes, you can buy fractional shares of Wave Life Sciences with INDmoney app.

What are the documents required to start investing in Wave Life Sciences stocks?

To start investing in Wave Life Sciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.